Buy Thymosin Alpha-1 Peptide Lithuania
Buy Thymosin Alpha-1 (Tα1), a synthetic peptide that enhances immune system responses by stimulating T cells, crucial for fighting infections and diseases. It has been used in treatments for chronic infections, autoimmune disorders, and some cancers, with ongoing research into its role in immunotherapy.
Shop our Full Range of Thymosin Alpha-1 Peptides
-
TWIN PACKS
Thymosin Alpha-1 Peptide Vial
Price range: £56.25 through £101.25 This product has multiple variants. The options may be chosen on the product page -
Sale!
Thymosin Alpha1 Pre-Mixed Pen 10mg Peptide
Price range: £58.83 through £158.84 This product has multiple variants. The options may be chosen on the product page -
Thymosin Alpha-1 Nasal Spray
Price range: £64.25 through £123.50 This product has multiple variants. The options may be chosen on the product page -
NEWBPC-157 Thymosin Alpha-1 GHK-Cu Stack
Original price was: £82.71.£74.43Current price is: £74.43. -
NEWThymosin Alpha-1 LL-37 VIP Peptide Stack
Original price was: £111.88.£100.69Current price is: £100.69. -
Sale!
Thymosin Alpha-1 LL-37 Nasal Stack
Price range: £99.08 through £189.16 This product has multiple variants. The options may be chosen on the product page -
Sale!
LL-37 Thymosin Alpha-1 Peptide
Price range: £85.58 through £94.56 This product has multiple variants. The options may be chosen on the product page
What Is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1) is a lab-made peptide derived from prothymosin alpha, a protein naturally found in the human body. Discovered in 1977, this 28 amino acid peptide is important for boosting and supporting the immune system. It works by stimulating the production and activity of T cells, key white blood cells responsible for fighting infections, regulating the immune system, and protecting the body from diseases.
Thanks to its powerful immunomodulatory properties, Tα1 has become a valuable tool in medical treatments. Tα1 has been used to treat autoimmune disorders, chronic infections, and some types of cancer. It is produced by stromal cells in the thymus gland and is encoded by the PTMA gene. Tα1 supports the immune system by boosting T-cell maturation and activity, making it a promising option in immunotherapy. Its safety and effectiveness have made it an important area of research in immune health.
Thymosin Alpha-1 Mechanism Of Action
Thymosin Alpha-1 (Tα1) is a strong immunomodulatory agent that boosts the body’s natural defenses. It works by interacting with key parts of the immune system, helping to strengthen immune responses and address various medical conditions.
One of Tα1’s primary functions is its interaction with immune cells, including T cells, dendritic cells, and natural killer cells (NK). It promotes the maturation and differentiation of T cells, which are essential for adaptive immunity. By increasing the expression of markers and receptors on these cells, Tα1 enhances their ability to recognize and respond effectively to antigens and pathogens.
Tα1 also modulates cytokine production, particularly boosting the expression of interferon-α (IFN-α) and interferon-γ (IFN-γ). Cytokines play a crucial role in defending against viruses by stopping viral replication and boosting the body’s ability to fight infections. This makes Tα1 an important therapeutic option for viral infections and related conditions.
Beyond its immune-boosting properties, Tα1 exhibits antioxidative and anti-inflammatory effects. It helps regulate oxidative stress and inflammation by modulating key markers and pathways, reducing cellular damage, and controlling inflammatory responses. These properties are especially beneficial in managing chronic inflammatory and autoimmune conditions.
Another significant function of Tα1 is its ability to enhance antigen presentation. Tα1 enhances the ability of dendritic cells to present antigens, making it easier for them to process and display antigens to T cells. This is essential for triggering specific immune responses, helping the body better recognize and eliminate infected or cancerous cells.
These diverse mechanisms highlight Tα1’s clinical potential. Studies have demonstrated its effectiveness in treating chronic infections, immune deficiencies, and certain malignancies. Its ability to modulate immune responses positions it as a versatile therapeutic agent with broad applications across various medical conditions.
Understanding how Tα1 works highlights its therapeutic benefits and supports its use in clinical practice, helping to improve outcomes for patients with immune-related disease
Source: PubChem
Structure of Thymosin Alpha-1
Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
Molecular Formula: C129H215N33O55
Molecular Weight: 3108.3 g/mol
PubChem CID: 16130571
What Are The Research Benefits of Thymosin Alpha-1?
Immune Modulation: Buy Thymosin Alpha-1 to enhance the immune system’s efficiency, making it a powerful tool for studying immune responses in various conditions. By boosting T-cell activity and promoting the production of cytokines, Tα1 helps improve the body’s ability to fight infections and may be beneficial in treating immune-related diseases.
Synergy with Antiretroviral Therapy: It may offer synergistic benefits when used with active antiretroviral therapy (ART) for treating HIV/AIDS. ART is the cornerstone of HIV treatment, reducing viral loads and improving patient outcomes.
Lithuania Research suggests that its immunomodulatory properties can enhance immune reconstitution, aiding in viral suppression and reducing opportunistic infections. This combination warrants further investigation to optimize treatment strategies for HIV/AIDS patients, ensuring comprehensive care and improved quality of life.
Oncology Research: Its use as an adjunct in cancer immunotherapy can offer significant insights into improving treatment efficacy and patient outcomes. By enhancing the body’s immune response to target cancer cells more effectively, it holds the potential to revolutionize current therapeutic approaches and provide new hope for Lithuania patients battling various types of cancer.
Numerous Lithuania clinical studies have demonstrated promising outcomes for the use of thymosin alpha 1 in patients with metastatic melanoma, breast cancer, lung cancer, and hepatocellular carcinoma.
Autoimmune Disorders: Lithuania Research can examine its potential to modulate immune responses in autoimmune diseases, such as rheumatoid arthritis or lupus. This could lead to the development of novel therapeutic approaches that specifically target and regulate immune system activity, offering hope for more effective treatments.
Infectious Diseases: Studying this peptide could provide valuable data on combating chronic infections, enhancing immune system responses, and improving patient recovery times. This research may lead to new treatments for a variety of persistent infections, ultimately contributing to better overall health outcomes.
Vaccine Development: It may assist in enhancing the immune response to vaccines, leading to more effective immunisation strategies. This could result in higher efficacy rates, better protection against diseases, and potentially fewer doses needed to achieve immunity.
Anti-inflammatory Properties: Understanding its role in reducing inflammation can pave the way for novel treatments for various inflammatory conditions. By reducing oxidative damage in tissues, it safeguards against multiple diseases and enhances general health. This could potentially lead to breakthroughs in managing chronic diseases, such as arthritis, asthma, and certain cardiovascular issues, thereby improving the quality of life for many individuals.
Cellular Mechanisms: Investigating how it influences T-cell maturation and activity can uncover critical aspects of immune system functioning. This Lithuania research can provide insights into the pathways through which it enhances immune responses, shedding light on potential therapeutic applications for immune-related disorders. Additionally, understanding these mechanisms may reveal new strategies for modulating immune activity in various diseases.
Combination Therapies: Research can focus on its synergistic effects when used alongside other treatments, such as chemotherapy or radiation, broadening therapeutic horizons and potentially enhancing patient outcomes. This approach could lead to more effective and personalized treatment plans.
Personalised Medicine: The study of Tα1 in different genetic backgrounds could support the development of more personalised treatment protocols by tailoring therapies to individual genetic profiles. This approach could improve peptide therapy efficacy and reduce adverse effects, ultimately leading to better patient outcomes.
Buy Thymosin Alpha-1 Lithuania for research online today!
Buy Thymosin Alpha-1 and LL-37 (CAP-18) Stack
Buy Thymosin Alpha-1 10mg and LL-37 2mg peptide stack from Direct Peptides, available as premium lyophilized powder in vials for subcutaneous injections. TA1 is known for enhancing immune function by supporting T-cell activity and cytokine production, helping to fight infections, autoimmune disorders, and certain cancers.
LL-37 adds strong antimicrobial properties, targeting bacteria, viruses, and fungi while aiding wound healing and immune regulation. Together, these peptides work to boost immune responses and improve infection control effectively.
This stack is also available in a convenient nasal format here.
Buy Thymosin Alpha-1 Peptide Nasal Spray
Buy Thymosin Alpha-1 nasal spray, now available in 15ml and 30ml glass spray bottles at Direct Peptides Lithuania. The Ta-1 nasal spray provides a simple alternative to injections, offering quick systemic effects through the nasal lining.
It has potential in research areas such as immune system support, vaccine improvement, antiviral treatments, reducing inflammation, and neuroprotection. This makes it valuable for both preclinical and clinical studies.
Frequently Asked Questions (FAQs) about Thymosin Alpha-1
What are the primary uses of Thymosin Alpha-1?
Tα1 is primarily utilised in treating chronic infections, enhancing immune system function, and as an adjunct therapy in cancer immunotherapy. It is also used in research settings to study its protective effects on immune modulation and autoimmune disorders.
How should Thymosin Alpha-1 be stored?
Tα1 peptide vial should be stored at -20°C to maintain its stability and efficacy. Once reconstituted, it should be used immediately. If not possible, it can be stored at 4°C for short periods, or aliquoted and frozen at -80°C for long-term storage, avoiding repeated freeze-thaw cycles.
Are there any side effects associated with Thymosin Alpha-1?
Thymosin Alpha-1 is generally well-tolerated, with minimal side effects. However, as with any therapeutic peptide, there may be potential for allergic reactions or site-specific discomfort depending on the delivery method. It is recommended to administer under professional guidance.
Can Thymosin Alpha-1 be used in combination with other treatments?
Yes, Tα1 can be used in combination with other therapies, especially in the context of cancer immunotherapy and treatments for chronic infections. As it modulates immune function, it can potentially enhance the efficacy of other treatments.
How quickly can one expect to see results from Thymosin Alpha-1?
The timeframe for observing results with Tα1 may vary based on individual conditions and the specific objectives of the research.
Some subjects might exhibit improvements within a few weeks, whereas long-term studies, particularly those focusing on chronic conditions or complex immune responses, might observe significant changes over several months.
Consistent administration, as outlined in research protocols and guided by healthcare professionals, is crucial for achieving optimal outcomes and accurate data collection.
Is Thymosin Alpha-1 Legal?
You can buy Thymosin Alpha-1 (Tα1) from Direct Peptides strictly for research purposes. A prescription drug version, marketed under the brand name Zadaxin, is officially approved for medical use in several countries, including the United States Food and Drug Administration (FDA).
Healthcare providers can prescribe it for the treatment of hepatitis B, chronic hepatitis C, and to support cancer therapy, following local medical guidelines. Researchers using Tα1 must comply with ethical and regulatory standards. Direct Peptides is committed to providing high-quality, authentic Tα1 specifically for research applications.
Summary of Research Applications
- Boosts immune response
- Enhances T-cell activity
- Fights chronic infections
- Supports cancer therapy
- Aids in autoimmune disorders
- Treats chronic hepatitis B
- Potential sepsis treatment
- Promotes dental healing
- Broad applications in clinical use
- Naturally occurring and safe
Thymosin Alpha-1 Peptide Quality Assured
At Direct Peptides Lithuania, we provide high-quality TA-1 peptides with 99% purity, produced using strict synthesis standards.
Our Thymosin Alpha-1 is designed for superior purity, ensuring optimal therapeutic effectiveness.
View the High Performance Liquid Chromatography (HPLC) Certificate here.
References For Further Reading
[1] F.Pei, X.Guan, and J.Wu (2018) Thymosin alpha 1 treatment for patients with sepsis – Expert Opinion on Biological Therapy, Volume 18, 2018 – Issue sup1, Pages 71-76.
[2] C.Li, L.Bo, Q.Liu, and F.Jin (2015) – Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis – Int J Infect Dis, Volume 33, April 2015, Pages 90-96.
[3] J.Wu, L.Zhou, J.Liu, et al (2013) The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial – Critical Care, 2013 Jan 17, Volume 17 (Issue 1), R8.
[4] R.King, and C. Tuthill (2016) Chapter Seven – Immune Modulation with Thymosin Alpha 1 Treatment – Vitamins and Hormones, Volume 102, 2016, Pages 151-178.
[5] W.T.Y.Loo, Y.D.Dou, W.K.J.Chou, and M.Wang (2007) Thymosin alpha 1 provides short-term and long-term benefits in the reimplantation of avulsed teeth: a double-blind randomized control pilot study – The American Journal of Emergency Medicine, 2008 Jun;26(5):574-7.
[6] E.Garaci, C.Favalli, F.Pica, et al (2007) – Thymosin Alpha 1 – Annals of the New York Academy of Sciences, Volume 1112, Issue 1, Thymosins in Health and Disease First International Symposium, September 2007, Pages 225-234.
[7] C.Costantini, M.M.Bellet, M.Pariano, et al (2019) A Reappraisal of Thymosin Alpha1 in Cancer Therapy – Frontiers in Oncology, 06 September 2019, Sec. Cancer Immunity and Immunotherapy, Volume 9.
[8] F.Pica, R.Gaziano, I.A.Casalinuovo, et al (2018) Serum thymosin alpha 1 levels in normal and pathological conditions – Expert Opinion on Biological Therapy, 2018 Jul, Volume 18 (supplement 1), Pages 13-21.
[9] X.Wu, J.Jia, and H.You (2015) Thymosin alpha-1 treatment in chronic hepatitis B – Expert Opinion on Biological Therapy, Feb 2015, Volume 15, Issue Sup 1, Pages 129-132.
[10] C.Matteucci, S.Grelli, E.Balestrieri, et al (2017) Thymosin alpha 1 and HIV-1: recent advances and future perspectives – Future Microbiology, 2017 Feb, Volume 12, Pages 141-155.
[11] A.Dominari, D.Hathaway III, K.Pandav, et al (2020) Thymosin alpha 1: A comprehensive review of the literature – World Journal of Virology, 2020 Dec 15, Volume 9 (Issue 5), Pages 67–78.
[12] J Kharazmi-Khorassani and A Asoodeh (2019) Thymosin alpha-1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549) – Environmental Toxicology, 2019 Aug, Volume 34 (Issue 8), Pages 941-949.
Why Choose Direct Peptides Lithuania?
Direct Peptides offers a wide range of Tα1 peptide formulations, including sterile vials, nasal sprays, and pre-mixed peptide pens. Researchers can also find essential accessories like bacteriostatic water for reconstitution. Shop confidently for Thymosin Alpha-1 peptides online today!
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Lithuania Direct Peptides website: https://lithuania.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
Related Posts
Synergistic Power Of Peptide Stacks
A comprehensive look at the potential benefits of combining peptides in a stack to elevate their individual .
Is Your Immune System Weak?
Direct Peptides explores the benefits and applications of Thymosin Alpha-1 (Tα1) for enhancing immune function.
The Benefits Of Thymosin Alpha-1 In Treating Cystic Fibrosis
A closer look at how Thymosin Alpha-1 an immune modulator could potentially help treat cystic fibrosis.